JP2004505899A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004505899A5 JP2004505899A5 JP2002517006A JP2002517006A JP2004505899A5 JP 2004505899 A5 JP2004505899 A5 JP 2004505899A5 JP 2002517006 A JP2002517006 A JP 2002517006A JP 2002517006 A JP2002517006 A JP 2002517006A JP 2004505899 A5 JP2004505899 A5 JP 2004505899A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020000046179A KR100730768B1 (ko) | 2000-08-09 | 2000-08-09 | 5'-데옥시-ｎ-알킬옥시카르보닐-5-플루오로사이토신-5'-카르복실산 및 그 유도체와 이들의 제조방법 |
| KR1020010044193A KR20030009649A (ko) | 2001-07-23 | 2001-07-23 | Ν-알키닐옥시카르보닐-5-플루오로시토신 유도체, 그제조방법 및 이를 유효성분으로 포함하는 항암제 |
| PCT/KR2001/001351 WO2002011668A2 (fr) | 2000-08-09 | 2001-08-08 | 5 deoxy-n-(substitue oxycarbonyle)-5-fluorocytosine et ses derives ; methode de preparation et composition anticancereuse renfermant ces substances comme principes actifs |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004505899A JP2004505899A (ja) | 2004-02-26 |
| JP2004505899A5 true JP2004505899A5 (fr) | 2005-02-24 |
Family
ID=26638291
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002517006A Pending JP2004505899A (ja) | 2000-08-09 | 2001-08-08 | ５’−デオキシ−ｎ−（置換されたオキシカルボニル）−５−フルオロシトシン及びその誘導体、その製造方法、並びに、これを有効性分として含む抗癌剤組成物 |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP1311524A2 (fr) |
| JP (1) | JP2004505899A (fr) |
| CN (1) | CN1446225A (fr) |
| AU (1) | AU2001278804A1 (fr) |
| WO (1) | WO2002011668A2 (fr) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20100216736A2 (en) * | 2006-07-21 | 2010-08-26 | Taiho Pharmaceutical Co., Ltd. | 2'-cyanopyrimidine nucleoside compound |
| CN101993464B (zh) * | 2009-08-19 | 2014-07-23 | 成都弘达药业有限公司 | 一种卡培他滨的制备方法 |
| CN103897004B (zh) * | 2012-12-27 | 2017-05-31 | 鲁南制药集团股份有限公司 | 一种卡培他滨的合成方法 |
| CA3027118C (fr) * | 2016-06-28 | 2023-08-15 | Cellix Bio Private Limited | Compositions et methodes pour le traitement du cancer |
| CN110831605A (zh) * | 2017-04-26 | 2020-02-21 | 托马斯·I.·卡尔曼 | 多靶标的核苷衍生物 |
| JP2021534085A (ja) * | 2018-08-03 | 2021-12-09 | セリックス バイオ プライヴェート リミテッドCellix Bio Private Limited | 癌治療のための組成物及び方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5968914A (en) * | 1987-10-28 | 1999-10-19 | Pro-Neuron, Inc. | Treatment of chemotherapeutic agent and antiviral agent toxicity with acylated pyrimidine nucleosides |
| US5204466A (en) * | 1990-02-01 | 1993-04-20 | Emory University | Method and compositions for the synthesis of bch-189 and related compounds |
| US5914331A (en) * | 1990-02-01 | 1999-06-22 | Emory University | Antiviral activity and resolution of 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane |
| US5276151A (en) * | 1990-02-01 | 1994-01-04 | Emory University | Method of synthesis of 1,3-dioxolane nucleosides |
-
2001
- 2001-08-08 EP EP01957021A patent/EP1311524A2/fr not_active Withdrawn
- 2001-08-08 CN CN01813741A patent/CN1446225A/zh active Pending
- 2001-08-08 WO PCT/KR2001/001351 patent/WO2002011668A2/fr not_active Application Discontinuation
- 2001-08-08 AU AU2001278804A patent/AU2001278804A1/en not_active Abandoned
- 2001-08-08 JP JP2002517006A patent/JP2004505899A/ja active Pending